David A. Siegel Ardelyx, Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARDX
# of Institutions
197Shares Held
140MCall Options Held
1.25MPut Options Held
1.52M-
Janus Henderson Group PLC London, X022MShares$116 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.1MShares$90.3 Million0.0% of portfolio
-
State Street Corp Boston, MA14.1MShares$74.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$70.7 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.81MShares$36 Million0.8% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $816M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...